ESAB Corp — Form 8-K
Filed November 4, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 52/100
What the filing says
ESAB reported Q3 2026 sales of $824.5M (up 13.3% reported, +2.3% core organic). Core adjusted EBITDA reached $156M with 19.8% margin (+40 bps YoY). However, FY2026 guidance was significantly reduced: core organic growth now 1.6%-2.0% (down from 2.0%-4.0%), and core adjusted EBITDA forecast cut to $603-607M (from $615-625M). Core adjusted EPS guidance lowered to $5.28-5.33 (from $5.40-5.50). Growth is driven primarily by M&A (9.5% contribution) and currency effects (2.0%), not underlying business momentum.
Why this rating
Significant miss on organic growth and full-year earnings guidance relative to company size (~$7.6B market cap). Margin expansion offset by weak 1.6%-2.0% organic growth and $18-22M EBITDA miss material to ~0.3-0.4% of company value, but not transformational.
See more from November 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.